Immunomedics (IMMU) - moderated | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Immunomedics (IMMU) - moderated

An SI Board Since September 2006

Posts	SubjectMarks	Bans	Symbol
63361	356	15	IMMU

Emcee: idahoranch1	Type: Moderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
62743	Therein lies the difference. The sava/avxl OLEs are "generating additional	ghettogoulash	-	8/2/2024
62742	Are you up for adopting….:). We can only hope that someone (Sava) gets us all h	rodneyh07	-	8/2/2024
62741	Any thoughts on whether the short term price action - exponential rise in SP - i	Olecranon	1	8/2/2024
62740	Stockdoc: Matt Nachtrab is an individual who owns over 2 million shares of SAVA	plhky3465	2	8/2/2024
62739	the OLE is more than allowing patients who are doing well to continue. In many c	scorman1	1	8/2/2024
62738	I'm still having a hard time making sense of the meaning of the OLE. Can yo	stockdoc77	-	8/2/2024
62737	For those interested in FDA's 2024 guidance re Alzheimers trials: fda.gov	weatherproof	-	8/2/2024
62736	>> Biogen's P4 was not generating additional data. It's sole purpo	weatherproof	-	8/2/2024
62735	Perfect, Stew! I vote for that outcome. :o)	weatherproof	-	8/2/2024
62734	Scorman, it would be full approval, not AA.	ghettogoulash	-	8/2/2024
62733	Biogen's P4 was not generating additional data. It's sole purpose was to	ghettogoulash	-	8/2/2024
62732	On SAVA, let me make it simple in a few words: Nov first phase 3 shows x% of pat	scorman1	2	8/1/2024
62731	Yes, that was one of the studies generating additional data post AA. They also	weatherproof	-	8/1/2024
62730	Take Biogen's P4 for Aduhelm as an example: "The study, as previously	ghettogoulash	-	8/1/2024
62729	Missling said that? Doesn't surprise me.	ghettogoulash	-	8/1/2024
62728	That's sort of where I started the thread a few days ago. I mentioned that	weatherproof	-	8/1/2024
62727	My bad. But the same applies. A confirmatory trial would have to be a standard R	ghettogoulash	-	8/1/2024
62726	I didn't say for AA. I said as a post-marketing confirmatory trial should A	weatherproof	-	8/1/2024
62725	Almost zero chance OLE data would be considered by the FDA for AA. Not only is i	ghettogoulash	-	8/1/2024
62724	Thanks, yes, SAVA.	weatherproof	-	8/1/2024
62723	Here is the salient point in the aforementioned FDA guidance on AVXL's expla	weatherproof	1	8/1/2024
62722	When you say CASA you really mean SAVA right? Also, I invited Matt Nachtrab to	plhky3465	2	8/1/2024
62721	My query goes to something that I feel is being missed by the responses here. L	weatherproof	2	8/1/2024
62720	P3 OLE will not be a factor in drug approval. The only point about the company s	ghettogoulash	1	8/1/2024
62719	That is a great question. Unfortunately, I believe the company is a one-trick po	jhcimmu	-	7/31/2024

Go to reply# or date (mm/dd/yy):